Carregant...
Are we giving biologics too much time? When should we stop treatment?
The optimal duration of biological treatment, particularly anti-TNF, in inflammatory bowel disease (IBD) is a very important question both for patients and physicians. There is no published evidence to clearly and definitely answer this question. However data on natural history of IBD, long term saf...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The WJG Press and Baishideng
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2746340/ https://ncbi.nlm.nih.gov/pubmed/18810771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.5528 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|